| Literature DB >> 36006197 |
Dabor Résière1,2, Jonathan Florentin1, Hossein Mehdaoui1, Zakaria Mahi3, Papa Gueye1, Didier Hommel2, Jean Pujo3, Flaubert NKontcho4, Patrick Portecop5, Rémi Nevière6, Hatem Kallel2, Bruno Mégarbane7.
Abstract
Ciguatera poisoning (CP) is one of the most common causes worldwide of marine poisoning associated with fish consumption from tropical areas. Its incidence is underreported. CP cases seem to increase with grouped cases reported during summer. Exposure to ciguatoxins, toxins responsible for CP with sodium-channel agonistic, voltage-gated potassium channel blocking, cholinergic, and adrenergic activities, may result in a large spectrum of manifestations. We aimed to describe the clinical characteristics, management, and outcome of CP in Martinique, French West Indies. We conducted an observational retrospective single-center study during six years (October 2012 to September 2018) including all CP patients managed by the prehospital medical services, admitted to the university hospital emergency department, or declared to the regional health agency. A total of 149 CP patients (81 females/63 males; median age, 46 years (interquartile range, 34-61)) were included. Acute features consisted in general (91%; mainly, myalgia pruritus, and asthenia), gastrointestinal (90%; mainly diarrhea, abdominal pain, and nausea), neurological (72%; mainly, paresthesia, dysgeusia, and impairment of hot/cold feeling), and cardiovascular manifestations (22%; bradycardia, hypotension, and heart conduction disorders). Management was supportive. No patient died but symptoms persisted in 40% of the 77 patients with follow-up at day 15. CP was mainly attributed to the ingestion of trevallies (59%), snappers (13%), and king mackerels (8%) with collective contaminations (71%). Unusual fish (tuna, salmon, and spider conchs) were suspected in rare cases. Ingestion of trevallies was associated with significantly higher persistent symptoms (odds ratio, 3.00; 95% confidence interval, (1.20-8.00); p = 0.03). CP incidence was 0.67 cases per 10,000 patient-years in Martinique over the study period. To conclude, CP represents an increasing public health issue in Martinique, as is the case in other Caribbean islands. Patients present usual but possibly life-threatening features. Outcome is excellent despite frequently prolonged manifestations.Entities:
Keywords: French West Indies; Martinique; ciguatera; ciguatoxin; fish; poisoning
Mesh:
Substances:
Year: 2022 PMID: 36006197 PMCID: PMC9415704 DOI: 10.3390/toxins14080535
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 5.075
Reported incidence of ciguatera poisoning in the world.
| Region | Period | Incidence | Reference |
|---|---|---|---|
| Martinique | 1996–2006 | 0.20 | [ |
| Reunion (Indian Ocean) | 2000–2010 | 0.20 | [ |
| Guadeloupe | 1996–2006 | 0.30 | [ |
| Guadeloupe | 2013–2016 | 1.47 | [ |
| Florida | 2000–2011 | 5.6 | [ |
| French Polynesia (Pacific Ocean) | 2016 | 18.0 | [ |
| Virgin Islands | 1996–2006 | 19.9 | [ |
| Antigua | 1996–2006 | 34.4 | [ |
| Montserrat | 1996–2006 | 58.6 | [ |
| Pacific Island Countries and Territories | 1998–2008 | 194 | [ |
Figure A1Map of geographical areas in Martinique where ciguatera poisonings were reported in 2012–2018.
Clinical manifestations in 149 patients diagnosed with ciguatera poisoning in Martinique, French West Indies, in 2012–2018.
| Clinical Characteristics | Prevalence or Value |
|---|---|
|
|
|
| Body temperature † | 37.0 °C (36.0–37.1) |
| Myalgia | 94/149 (63%) |
| Pruritus | 94/149 (63%) |
| Asthenia | 61/149 (41%) |
| Hypothermia (temperature ≤36.5 °C) * | 26/66 (39%) |
| Arthralgia | 54/149 (36%) |
| Chills | 49/149 (33%) |
| Headaches | 42/149 (28%) |
| Dizziness | 34/149 (23%) |
| Malaise | 28/149 (19%) |
| Sweating | 6/149 (4%) |
| Dyspnea | 5/149 (3%) |
| Limb edema | 5/149 (3%) |
|
|
|
| Diarrhea | 119/149 (80% |
| Abdominal pain | 102/149 (69%) |
| Nausea | 88/149 (59%) |
| Vomiting | 80/149 (54%) |
|
|
|
| Paresthesia | 77/149 (52%) |
| Dysgeusia | 45/149 (30%) |
| Impairment of feeling of hot and cold | 40/149 (27%) |
| Touch disorder | 37/149 (25%) |
| Dysuria | 25/149 (17%) |
| Reversal of hot and cold | 24/149 (16%) |
| Balance/coordination/language impairment | 24/149 (16%) |
| Visual disturbance | 23/149 (15%) |
| Behavioral disorder | 17/149 (11%) |
| Pain in cold | 11/149 (7%) |
|
|
|
| Heart rate † | 69 bpm (50–87) |
| Systolic blood pressure † | 112 mmHg (97–130) |
| Diastolic blood pressure † | 68 mmHg (59–78) |
| Bradycardia (heart rate <60 bpm) * | 24/66 (36%) |
| Hypotension (systolic blood pressure <90 mmHg) * | 10/66 (15%) |
| ECG abnormalities * | 10/66 (15%) |
| Severe cardiovascular features #,* | 8/66 (12%) |
| Palpitations | 5/149 (3%) |
|
|
|
| Chronic pain | 20/77 (26%) |
| Chronic neurological manifestations | 15/77 (20%) |
| Chronic asthenia | 11/77 (14%) |
| Chronic pruritus | 10/77 (13%) |
† expressed as median (interquartile range); # severe cardiovascular features were defined as heart rate <40 bpm or systolic blood pressure <80 mmHg on admission; * determined in the 66 patients managed in the emergency department with available vital signs and electrocardiograms; ** determined in the 77 patients followed-up at the clinical toxicology consultation (n = 39) or by phone call (n = 38).
Management in sixty-six patients diagnosed with ciguatera poisoning and managed in the emergency department of the university hospital of Martinique, French West Indies, in 2012–2018.
| Management at the Emergency Department | Prevalence or Value |
|---|---|
| Supportive care | 42/66 (64%) |
| Fluids (0.9% NaCl) | 11/66 (17%) |
| 20% mannitol infusion | 11/66 (17%) |
| Intravenous atropine administration | 10/66 (15%) |
| Hospitalization | 24/149 (16%) |
| Length of hospital stay † | 1 days (1–2) |
| Follow-up at the clinical toxicology consultation | 39/66 (59%) |
† expressed as median (interquartile range).
Ingested fish that caused ciguatera poisoning in 149 patients in Martinique, French West Indies, in 2012–2018.
| Incriminated Fish | Number of Incriminated Fish | Number of Intoxicated Patients |
|---|---|---|
| 50 | 87 | |
| 14 | 19 | |
| 4 | 10 | |
| 3 | 4 | |
| 2 | 6 | |
| 2 | 3 | |
| 1 | 9 | |
| 1 | 1 | |
| 1 | 1 | |
| 1 | 1 | |
| Mixed fish | 1 | 4 |
| Not described | 4 | 4 |
Comparison of clinical characteristics according to the fish responsible for ciguatera poisoning in 145 patients in Martinique †, French West Indies, in 2012–2018.
| Clinical Characteristics | Patients Intoxicated by Trevallies ( | Patients Intoxicated by Other Fish Species | |
|---|---|---|---|
| Fish head or viscera ingestion (N = 144) | 20/86 (24%) | 5/58 (9%) | 0.03 |
| Acute vomiting (N = 145) | 64/87 (74%) | 23/58 (40%) | <0.0001 |
| Acute nausea (N = 145) | 61/87 (70%) | 24/58 (41%) | 0.001 |
| Acute abdominal pain (N = 145) | 68/87 (78%) | 31/58 (53%) | 0.002 |
| Acute hypotension (N = 64) | 14/35 (40%) | 5/29 (17%) | 0.05 |
| Mannitol administration (N = 63) | 8/33 (24%) | 2/30 (6%) | 0.09 |
| Persistent symptoms (N = 74) | 19/36 (50%) | 9/36 (25%) | 0.03 |
† Four patients with unknown ingested fish were excluded from the analysis; persistent symptoms if present after the acute phase that usually lasts 1–14 days after fish ingestion.